|
||||||||||||||||||||||
![]() |
|
![]() |
![]() |
|
![]() MART-1:27-35 peptide vaccine A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus) ![]() ![]() ![]() ![]()
|
![]() |
![]() |
![]() |
![]() |
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
![]() A Service of the National Cancer Institute |
![]() |
![]() |